| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.085 | 0.002 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.004 |